Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes.
about
Use of RNA interference and complementation to study the function of the Drosophila and human 26S proteasome subunit S13The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its deathTargeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategiesInhibition of proteasomal degradation of rpn4 impairs nonhomologous end-joining repair of DNA double-strand breaks.Genome-wide analysis identifies MYND-domain protein Mub1 as an essential factor for Rpn4 ubiquitylation.Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome.The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle.Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegenerationProteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cellsThe ubiquitin proteasome system and myocardial ischemiaNuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in miceRegulation of proteasome activity in health and diseaseNrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cellsPAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasisMouse zygote-specific proteasome assembly chaperone important for maternal-to-zygotic transition.Progressively impaired proteasomal capacity during terminal plasma cell differentiation.Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.Purification of the Arabidopsis 26 S proteasome: biochemical and molecular analyses revealed the presence of multiple isoforms.Role of proteasomes in disease.Genomic analysis of Drosophila neuronal remodeling: a role for the RNA-binding protein Boule as a negative regulator of axon pruning.Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma.The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.Different Polyubiquitinated Bodies in Human Dendritic Cells: IL-4 Causes PaCS During Differentiation while LPS or IFNα Induces DALIS During MaturationProteasomal degradation of Rpn4 in Saccharomyces cerevisiae is critical for cell viability under stressed conditions.Basic leucine zipper protein Cnc-C is a substrate and transcriptional regulator of the Drosophila 26S proteasome.Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probessiRNA silencing of proteasome maturation protein (POMP) activates the unfolded protein response and constitutes a model for KLICK genodermatosis.Aging and dietary restriction alter proteasome biogenesis and composition in the brain and liverIdentification of mammalian protein quality control factors by high-throughput cellular imagingCellular stress response pathways and ageing: intricate molecular relationshipsValidation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicityBiodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma ModelRegulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α.Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib.Activities of Z-ajoene against tumour and viral spreading in vitro.Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.MURF2B, a novel LC3-binding protein, participates with MURF2A in the switch between autophagy and ubiquitin proteasome system during differentiation of C2C12 muscle cellsBortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.
P2860
Q24681220-77279418-F633-4EEA-9332-63077C3A3B5CQ26738549-8629C1B7-9624-4129-9D1D-CA05405027F4Q27026951-4E6CC7DF-1176-4771-B597-5CADFDF804A9Q27929905-A6894EFA-84FF-47AF-947A-2C2A1617891BQ27930957-FDCD7D8E-A9E6-4D4C-9F74-14420B82BD42Q27934022-DB1A64A1-B843-477C-A41D-47CBCC007BC5Q27938094-01D27280-263F-49FD-81BC-045B6BE32A4DQ28236609-A35EED45-150B-4550-B711-DC2780D61C84Q28243388-41C9E58E-2F12-402B-BC82-193D0A41ED4FQ28279454-5CCE2156-15A5-420E-A098-CE37236BDC1DQ28280898-1E9BEBD4-F770-4BB6-95FF-3DCEB8F20878Q28291312-58DA41E5-D5A4-46E2-9EEC-E4658BCFD1B7Q28392708-262D4D05-8118-447F-8D71-5290A2991763Q28394410-644503A5-52B2-4E23-AD40-0B559AF43355Q28586356-DE85238F-4E32-4FF2-899B-37F7C936DBAFQ29347254-B7E20AC1-FBD9-4624-AABB-4F64E375E0DBQ30476988-B63FA252-A8F5-448D-A5DB-F9E43A9495FDQ30479870-7C718A6B-01BE-4EC0-AA10-EFFA963E14E5Q31026772-B90CC6CA-45D5-4CAF-9249-93943BF2356AQ33307877-A9D81B61-C0C4-49C6-A9BE-3E5D6813386FQ33343415-DAE6EE96-1B32-4CB4-98C2-14DB38BDC8D3Q33420278-4EF46D1C-7B97-491F-9376-D46AE6E97B23Q33554497-A8DFFC0D-F573-4140-9F90-3C98F63D7C87Q33556178-29B5900C-B5C2-4BA9-AE79-FB23CF2D9FE6Q33687819-B84C6541-A50E-48FB-BB6D-00C8038E1708Q33688804-C20B885C-0CC0-4618-A7F5-F9CEB087204AQ33768364-40B3AA33-21A3-4423-9800-4B04D316B48AQ34061291-A9B7794F-38FA-4942-993B-2AA18973C075Q34123701-721F05E8-438F-454E-A127-34012DADDA92Q34141824-CC7AB97E-7A84-4DEE-AF37-40F7A92F06D7Q34171255-A8D941F7-4334-497F-B3DD-E0C41564FEAFQ34185656-332CEC22-946D-4368-8413-F4ACDC57FF71Q34473136-53247B2B-2B49-45CD-9F09-D7088E963978Q34478543-1AD354FD-34CD-42CA-984A-259517C97428Q34521305-8B045C94-64DD-4EF9-8EE0-20FC16DFA988Q34608271-A4C46175-1198-47CF-B902-49FB36CEED82Q34631061-E98B6F9F-A003-45F7-9955-E237A895C1ABQ34644848-A576E7AD-7F5F-40ED-BC78-5090974DF76CQ35016908-38E087AC-6C67-4AA4-ABEC-5B2B8473AAFFQ35036537-D81DECB1-3792-438F-92FE-BC3328249984
P2860
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Inhibition of proteasome activ ...... tion of Mammalian proteasomes.
@en
type
label
Inhibition of proteasome activ ...... tion of Mammalian proteasomes.
@en
prefLabel
Inhibition of proteasome activ ...... tion of Mammalian proteasomes.
@en
P2093
P2860
P356
P1476
Inhibition of proteasome activ ...... tion of Mammalian proteasomes.
@en
P2093
Andrea Weller
Antje Ludwig
Dirk Heyken
Elke Krüger
Karl Stangl
Silke Meiners
P2860
P304
21517-21525
P356
10.1074/JBC.M301032200
P407
P577
2003-04-03T00:00:00Z